Using targeted next-generation sequencing analysis of tumor biopsies and germline DNA samples from mCRPC patients one study found that presence of deleterious DDR mutations in BRCA2, ATM, mismatch repair (MMR), and CDK12 genes was more frequent in patients with high tumor membranous PSMA expression [51]. The gene discussed is BRCA2; the disease is neoplasm.